Latest Articles

Publication Date
All News Scientific
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - BioSpace

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer BioSpace

Published: Oct. 20, 2025, 4:42 a.m.
Read Full Article
Emmy Nominee Dies of Endometrial Cancer: Jackie Burch Was 74 - PopCulture.com

Emmy Nominee Dies of Endometrial Cancer: Jackie Burch Was 74 PopCulture.com

Published: Oct. 20, 2025, 4:32 a.m.
Read Full Article
Cellular Senescence in Endometrium: A Pivotal Regulator in Physiological Remodeling and Pathological Disorders.

As a highly dynamic tissue, the endometrium undergoes complex remodeling during the menstrual cycle and pregnancy. Recent studies have revealed that cellular senescence plays a pivotal role in both physiological …

Published: Oct. 20, 2025, midnight
Read Full Article
decidualization endometriosis endometrium implantation failure intrauterine adhesions senescence spontaneous abortion thin endometrium
Tecentriq Plus Chemo Shows Comparable Survival in Endometrial Cancer - CUREtoday.com

Tecentriq Plus Chemo Shows Comparable Survival in Endometrial Cancer CUREtoday.com

Published: Oct. 19, 2025, 6:39 p.m.
Read Full Article
Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer - CancerNetwork

Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer CancerNetwork

Published: Oct. 19, 2025, 4:40 p.m.
Read Full Article
Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer - cancernetwork.com

Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer cancernetwork.com

Published: Oct. 19, 2025, 4:40 p.m.
Read Full Article
Exclusive: Sid Mukherjee’s Faeth nets $25M for endometrial cancer study - Endpoints News

Exclusive: Sid Mukherjee’s Faeth nets $25M for endometrial cancer study Endpoints News

Published: Oct. 19, 2025, 9:01 a.m.
Read Full Article
Giorgio Bogani: New Insights into POLE-Mutated Endometrial Cancer with Nodal Involvement - Oncodaily

Giorgio Bogani: New Insights into POLE-Mutated Endometrial Cancer with Nodal Involvement Oncodaily

Published: Oct. 18, 2025, 10:08 p.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Lelezard

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Lelezard

Published: Oct. 18, 2025, 12:47 p.m.
Read Full Article
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - The AI Journal

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen The AI Journal

Published: Oct. 18, 2025, 10:28 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!